Healthcare

ICON has facilitated many large consulting projects that deliver solutions based on Imperial’s world leading expertise on topics ranging from healthcare reform and policy to epidemiological surveys.

Our consultants are experienced in applying their knowledge and skill to challenges faced in both the public and private sectors and many are leading figures in organisations such as the World Health Organization, the World Bank and different bodies of the EU. Several have held public office and have designed and delivered successful healthcare strategies globally.

We have helped clients solve a range of problems:

 

HEALTH ECONOMICS

The expertise of leading health economists and a large amount of comparative data offers solutions on health system performance assessment, assessment of performance and quality of providers, incentive and payment and their impacts and the economic impact of disease.

 

INNOVATION IN HEALTHCARE

Innovation and organisational change across the healthcare supply chain, health systems performance and health services research, adoption, implementation and sustainability of innovation, service, technology and infrastructure planning and delivery, global health policy evaluation, design in healthcare and public health education.

 

EPIDEMIOLOGY EXPERTISE

Collecting, analysing and monitoring large cohorts, national and international cohort and population collections, global health research, medical and biostatistics.

 

E-HEALTH AND M-HEALTH

Development, implementation, regulation and evaluation of advanced ICT systems for e-health, health informatics to improve health system performance and public health, evidence to influence e-health policy, m-health app development and e-learning.

 

MOLECULAR DIAGNOSTICS UNIT (MDU)

The CPA-accredited Molecular Diagnostic Unit (MDU) provides fast, accurate diagnostic tests for the management of infectious and genetic diseases using latest technology, including next generation sequencing and UPLC. Through ongoing research and development of new diagnostic methods it strives to remain ahead of the field in diagnostic testing and clinical monitoring.

The MDU supports the HIV and HTLV trials of the Clinical Trials Centre and patient management for The National Centre for Human Retrovirology and Imperial College Healthcare Trust.

Work to date has been centred on HIV, hepatitis viruses and sexually transmitted infections – but the clinical requirements of other clients can be catered for, click for more details.

 

TRAINING IN HEALTHCARE

Our academics have provided training in public health and health economics in the UK and internationally.

Whether you need help with healthcare strategy or a comparative analysis on the reimbursement system for a drug, we can find the right people to help you solve a problem flexibly and responsively.

Advisory services

Product design, research methods, data analysis, technology evaluation for investment, technological innovation, patent evaluation, prototype and protocol development, policy, cyber security and more. Assisting museums, writers, film makers and artists to ensure creations scientifically sound.

Expert insight

Membership of Scientific Advisory Boards and Technical Panels, advice and guidance on drug development programmes, thought leadership, conference speakers, literature reviews and provision of foresight.

Analysis and testing

Use of the world-class specialist facilities and technicians at Imperial for projects ranging from aerodynamic measurements and medical imaging to structural testing and analysis.

Our consultants are world-leading experts in their field, committed to on-going research.

Related Insights

Factories of the Future

Factories of the Future

Additive manufacturing is an automated production process enabling complex 3D designs to be transformed into physical objects. Read about the benefits and implications. read more

Imperial’s response to COVID-19

Imperial’s response to COVID-19

Experts across a wide range of disciplines have been and are continuing to to keep government and society informed about COVID-19, save lives through vaccines and testing - and protect precious workforces like the NHS. read more

The future of urban air

The future of urban air

How could future technologies and social interventions change urban air for city dwellers? Hover over the map created by Imperial's researchers, futurists and our Tech Foresight team. read more

Related case studies

Neuropathic pain drug development

Neuropathic pain drug development

Our consultants shared their expertise in neuropathic pain area treatments to support Spinifex’s drug discovery and development programs. read more

Management of pests and vectors of disease

Management of pests and vectors of disease

Helping small-holder farmers with cost-effective techniques to manage pests and vectors of disease, reducing the use of chemical pesticides and promoting the efficiency of natural processes. read more

Hepatitis C genotype and drug resistance testing

Hepatitis C genotype and drug resistance testing

Genotype and resistance testing for new direct-acting antiviral (DAA) drugs designed to treat Hepatitis C virus (HCV). read more

Latest news

FREE Fetal Heart webinar – ON DEMAND

FREE Fetal Heart webinar – ON DEMAND

Catch up on the third in our series of four, educational webinars exploring Fetal Medicine. In this event we will explore cases where fetal cardiology, fetal medicine, clinical genetics and obstetric management are integrated in one patient pathway. Delivered by Imperial’s Professor Christoph Lees, and supported by GE HealthCare. read more

Imperial Consultants contribute to novel pain drug success

Imperial Consultants contribute to novel pain drug success

Australian pharmaceutical company, Spinifex Pharmaceuticals (“Spinifex”) has recently presented the clinical development of their lead product at the 14th World Congress of Pain®, highlighting the success of consultancy through Imperial Consultants. read more

COVID research news shared with international community

COVID research news shared with international community

The Imperial Global Science Policy Forum (IGSPF), attended by 300 delegates from global universities, Embassies, and industry focused on Imperial's role in the international response to the COVID-19 pandemic. read more